Evaluation of suspected malignancies: Difference between revisions
Jump to navigation
Jump to search
m →Molecular workup: Bolded |
→Histopathologic type: Generally |
||
| Line 91: | Line 91: | ||
===Further histopathologic subtyping and grading=== | ===Further histopathologic subtyping and grading=== | ||
Beyond determining overall malignancy diagnosis (such as adenocarcinoma), probable origin and staging, classification of tumors into a specific histopathologic type or grade is generally of relatively less value. In cases of clearly non-malignant tumors where it is difficult to determine the specific histopathologic type or grade, it is generally acceptable to conclude the evaluation and report it as such, unless the clinician specifically requests otherwise. For potentially malignant or high-risk tumors, typing and grading often still affects the management. | Beyond determining overall malignancy diagnosis (such as adenocarcinoma), probable origin and staging, classification of tumors into a specific histopathologic type or grade is generally of relatively less value. In cases of clearly non-malignant tumors where it is difficult to determine the specific histopathologic type or grade, it is generally acceptable to conclude the evaluation and report it as such, unless the clinician specifically requests otherwise. For potentially malignant or high-risk tumors, typing and grading often still affects the management, but generally much less so than staging. | ||
{{Undifferentiated malignancy}} | {{Undifferentiated malignancy}} | ||